Effect of Ecopipam, a Selective Dopamine-1 Receptor Antagonist, on Tic Characteristics as Assessed by the YGTSS: Results From the Phase 2b Randomized, Double-blind, Placebo-controlled Clinical Trial in Tourette Syndrome

被引：0
|
作者：
Gilbert, D. L.
Karkanias, G. B.
Atkinson, S. D.
Munschauer, F.
Wanaski, S.
Cunniff, T.
机构：
来源：
ANNALS OF NEUROLOGY | 2025年 / 96卷
关键词：
Experimental Therapeutics; Movement Disorders;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
97
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [1] Effect of Ecopipam, a Selective Dopamine-1 Receptor Antagonist, on Tic Characteristics as Assessed by the YGTSS: Results from a Phase IIb Randomized, Double-blind, Placebo-controlled Clinical Trial in Tourette Syndrome
    Gilbert, D.
    Karkanias, G.
    Atkinson, S.
    Munschauer, F.
    Wanaski, S.
    Cunniff, T.
    MOVEMENT DISORDERS, 2024, 39 : S705 - S706
  • [2] Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study of Ecopipam in Children and Adolescents with Tourette Syndrome
    Mahableshwarkar, A.
    Dubow, J.
    Cunniff, T.
    Wanaski, S.
    MOVEMENT DISORDERS, 2022, 37 : S415 - S415
  • [3] A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome
    Gilbert, D.
    Murphy, T.
    Jankovic, J.
    Budman, C.
    Black, K.
    Kurlan, R.
    Coffman, K.
    McCracken, J.
    Juncos, J.
    Grant, J.
    Chipkin, R.
    MOVEMENT DISORDERS, 2017, 32 (12) : E15 - E15
  • [4] A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome
    Gilbert, D.
    Murphy, T.
    Jankovic, J.
    Budman, C.
    Black, K.
    Kurlan, R.
    Coffman, K.
    McCracken, J.
    Juncos, J.
    Grant, J.
    Chipkin, R.
    MOVEMENT DISORDERS, 2017, 32
  • [5] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE D1 RECEPTOR ANTAGONIST ECOPIPAM FOR CHILDREN AND ADOLESCENTS WITH TOURETTE'S DISORDER
    Murphy, Tanya K.
    Gilbert, Donald
    Budman, Cathy L.
    Black, Kevin J.
    Jankovic, Joseph
    Grant, Jon
    McCracken, James T.
    Coffman, Keith A.
    Juncos, Jorge
    Kurlan, Roger
    Chipkin, Richard E.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S241 - S241
  • [6] A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease
    Khasnavis, Tanya
    Torres, Rosa J.
    Sommerfeld, Barbara
    Garcia Puig, Juan
    Chipkin, Richard
    Jinnah, H. A.
    MOLECULAR GENETICS AND METABOLISM, 2016, 118 (03) : 160 - 166
  • [7] A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
    Lafayette, Richard
    Barbour, Sean
    Israni, Rubeen
    Wei, Xuelian
    Eren, Necmi
    Floege, Juergen
    Jha, Vivekanand
    Kim, Sung Gyun
    Maes, Bart
    Phoon, Richard K. S.
    Singh, Harmeet
    Tesar, Vladimir
    Lin, Celia J. F.
    Barratt, Jonathan
    KIDNEY INTERNATIONAL, 2024, 105 (06) : 1306 - 1315
  • [8] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
    Ratziu, V.
    de Guevara, L.
    Safadi, R.
    Poordad, F.
    Fuster, F.
    Flores-Figueroa, J.
    Arrese, M.
    Fracanzani, Anna L.
    Ben Bashat, D.
    Lackner, K.
    Gorfine, T.
    Kadosh, S.
    Oren, R.
    Halperin, M.
    Hayardeny, L.
    Loomba, R.
    Friedman, S.
    Sanyal, Arun J.
    NATURE MEDICINE, 2021, 27 (10) : 1825 - +
  • [9] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
    V. Ratziu
    L. de Guevara
    R. Safadi
    F. Poordad
    F. Fuster
    J. Flores-Figueroa
    M. Arrese
    Anna L. Fracanzani
    D. Ben Bashat
    K. Lackner
    T. Gorfine
    S. Kadosh
    R. Oren
    M. Halperin
    L. Hayardeny
    R. Loomba
    S. Friedman
    Arun J. Sanyal
    Nature Medicine, 2021, 27 : 1825 - 1835
  • [10] EFRUXIFERMIN (EFX) IN NONALCOHOLIC STEATOHEPATITIS WITH FIBROSIS: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2b TRIAL (HARMONY)
    Harrison, Stephen A.
    Frias, Juan P.
    Neff, Guy W.
    Abrams, Gary A.
    Lucas, Kathryn Jean
    Sanchez, William
    Gogia, Sudhanshu
    Sheikh, Muhammad Y.
    Behling, Cynthia
    Bedossa, Pierre
    Shao, Lan
    Fong, Erica
    De Temple, Brittany
    Shringarpure, Reshma
    Tillman, Erik J.
    Rolph, Timothy P.
    Cheng, Andrew
    Yale, Kitty
    HEPATOLOGY, 2023, 77 (05) : E122 - E122
12345